Methylene Blue for Vasoplegic Syndrome after Cardiac Surgery: Early Administration Improves Survival

BACKGROUND: Vasoplegic syndrome, defined by hypotension despite normal or increased cardiac output, is associated with high mortality after cardiopulmonary bypass. Methylene blue (MB) is reported to ameliorate vasoplegic syndrome through the nitric oxide pathway. We hypothesized that early administr...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Ann Thorac Surg
Main Authors: Mehaffey, J. Hunter, Johnston, Lily E., Hawkins, Robert B., Charles, Eric J., Yarboro, Leora, Kern, John A., Ailawadi, Gorav, Kron, Irving L., Ghanta, Ravi K.
Formato: Artigo
Idioma:Inglês
Publicado: 2017
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5523819/
https://ncbi.nlm.nih.gov/pubmed/28551045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.athoracsur.2017.02.057
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares